Table 3.
Risk factors for mortality
| No (n = 35) | Yes (n = 17) | Total (n = 52) | P value | |
|---|---|---|---|---|
| Gender (%) | .725 | |||
| Male | 23 (65.7) | 12 (34.2) | 35 (100) | |
| Female | 12 (70.6) | 5 (29.4) | 17 (100) | |
| Hemoglobin (g/dL ± SD) | 7.7 ± 2.6 | 8 ± 2.3 | 7.8 ± 2.5 | .763 |
| Clinical presentation (%) | < .001 | |||
| Hematemesis | 11 (50) | 11 (50) | 22 (100) | |
| Others | 24 (80) | 6 (20) | 30 (100) | |
| ECOG | .127 | |||
| I | 26 (74.3) | 9 (25.7) | 35 (100) | |
| II | 9 (52.9) | 8 (47.1) | 17 (100) | |
| Bleeding site (%) | .051 | |||
| Duodenum | 6 (60) | 4 (40) | 10 (100) | |
| Esophagus | 5 (41.6) | 7 (58.3) | 12 (100) | |
| Stomach | 24 (80) | 6 (20) | 30 (100) | |
| Active bleeding (%) | 15 (78.9) | 4 (21.1) | 19 (100) | .175 |
| Additional treatment (%) | 13 (76.5) | 4 (23.5) | 17 (100) | .326 |
| Re-bleeding (%) | 8 (66.7) | 4 (33.3) | 12 (100) | .957 |
| Groups (%) | .091 | |||
| APC | 19 (79.2) | 5 (20.8) | 24 (100) | |
| Control | 16 (57.1) | 12 (42.9) | 28 (100) |
APC: argon plasma coagulation; ECOG: Eastern Cooperative Oncology Group performance status.